The forecasted sales of analgesic medicine in Chile show a steadily increasing trend from 2024 to 2028, with values rising from 207.1 million USD PPP to 220.0 million USD PPP. This represents the following year-on-year variations: 1.64% from 2024 to 2025, 1.52% from 2025 to 2026, 1.50% from 2026 to 2027, and 1.43% from 2027 to 2028. Over the last two years, the sales have shown a consistent rise, indicating a robust market demand.
The Compound Annual Growth Rate (CAGR) from 2024 to 2028 stands at approximately 1.52%, reflecting modest yet steady growth over this period. As of 2023, the analgesic medicine market was valued at 204 million USD PPP, setting a baseline for the forecasted growth.
Future trends to watch for include potential impacts of healthcare policy changes, shifts in consumer preferences towards natural or alternative remedies, and advancements in medical technology that could either drive or hinder the demand for traditional analgesic medicines.
